跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 39 条关于
“RAD51”
全部
39
临床试验
18
药物
7
机构
0
资讯
14
去年
BRCA2 Mechanism Reveals Why PARP Inhibitors Work in Only Some Cancer Patients
去年
NCI Initiates $4.8 Million Clinical Trial of Senhwa's First-in-Class Cancer Drug CX-5461
2个月前
The Lactate–Lactylation Axis in Tumor Radioresistance: From Metabolic Adaptation to Therapeutic Targeting
2年前
Biomarker-Driven Clinical Trial Designs: Basket, Umbrella, and Platform Trials in Precision Medicine
2个月前
PYGO2 Identified as Key Driver of 1q21+ Multiple Myeloma Progression and Potential Therapeutic Target
去年
Pembrolizumab-Vorinostat Combination Shows Promise in Recurrent Squamous Cell Carcinoma
2年前
Lynparza Shows Promise as Non-Hormonal Therapy for Prostate Cancer with HRR Mutations
去年
Real-World Data Shows Olaparib Benefits mCRPC Patients with HRR Mutations
去年
Precision Medicine Oncology Pharmacists Emerge as Critical Players in Personalized Cancer Care
2年前
Rare RAD51C Mutation Unlocks Immunotherapy Success in Pancreatic Cancer Patient
第 1 页,共 2 页
上一页
下一页